Advaxis, Inc. to Present at the 9th Annual Biotechnology Industry Organization (BIO) Investor Forum Conference

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has been invited to present at the 9th Annual BIO Investor Forum at the Palace Hotel in San Francisco, CA, Tuesday, October 5, 2010 at 10:00 a.m. EDT.
MORE ON THIS TOPIC